Follow the 인트론바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 인트론바이오 has logged 37 insider filings. Market capitalisation: €79.5bn. The latest transaction was disclosed on 3 July 2026 (Purchase). Among the most active insiders: 윤성준. All data is free.
37
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,214 of 29,064 companies
30.8
score / 100
Value
17
Quality
45
FCF yld-8.7%
Earn yld-10%
EV/EBITDA·
ROE-12%
Gross mgn54%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.